This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

7 Stocks Under $10 Making Big Moves

Array BioPharma

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Array BioPharma (ARRY - Get Report) is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. This stock is trading up 5.4% at $3.68 in recent trading.

Today's Range: $3.49-$3.80

52-Week Range: $1.58-$3.53

Volume: 1.13 million

Three-Month Average Volume: 868,835

Shares of ARRY are ripping higher today after the company announced encouraging selumetinib results for phase II trials in ovarian cancer. Selumetinib was invented by Array and licensed to AstraZeneca.

From a technical perspective, ARRY is continuing a breakout pattern today now that the stock is comfortably above its recent breakout levels of $3.27 to $3.33. Volume so far is tracking in very strong and well above its average action of 868,835 shares.

Traders should now watch for ARRY to close above its next major overhead resistance level of $3.60. If we get that close today, then look for ARRY to uptrend toward $4 to $4.25 or possibly higher in the near future. Traders should consider long biased traders as long as ARRY is trending above $3.60 with strong upside volume flows.

Array shows up on a list of 7 Cancer Drug Stocks to Know Right Now.
2 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
OCZ $0.00 0.00%
SCEI $0.05 0.00%
ARRY $2.91 0.00%
OMN $5.18 0.00%
VRNG $1.60 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs